Article Information
History
- August 12, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gajender Aleti1,
- Jordan N. Kohn1,
- Emily A. Troyer1,
- Kelly Weldon3,6,
- Shi Huang2,3,
- Anupriya Tripathi2,6,
- Pieter C. Dorrestein2,3,6,7,
- Austin D. Swafford3,
- Rob Knight2,3,4,5 and
- Suzi Hong1,8,*
- 1Department of Psychiatry, University of California San Diego, La Jolla, CA 92093, United States of America
- 2Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, United States of America
- 3Center for Microbiome Innovation, University of California San Diego, La Jolla, CA 92093, United States of America
- 4Department of Computer Science and Engineering, University of California San Diego, La Jolla, CA 92093, United States of America
- 5Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, United States of America
- 6Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, United States of America
- 7Collaborative Mass Spectrometry Innovation Center, University of California San Diego, La Jolla, CA 92093, United States of America.
- 8Herbert Wertheim School of Public Health and Longevity Science, University of California San Diego, La Jolla, CA 92093, United States of America
- ↵*Corresponding author: Suzi Hong, PhD; s1hong{at}health.ucsd.edu
Posted August 12, 2021.
Salivary bacterial signatures in depression-obesity comorbidity are associated with neurotransmitters and neuroactive dipeptides
